Condition

Ductal Carcinoma in Situ

ClinicalTrials.gov condition label

Clinical trials42

Recruiting10

Common interventions25

Lead sponsors shown15

Clinical trials

42 shown

CAN1012 in Pre-Malignant DCIS and LCISNCT07408856 · 2026-09-16

Novel Cavity Marking Technique in Breast Cancer Patients Undergoing Breast Conservation Surgery With Oncoplastic Reconstruction for the Delivery of Adjuvant Radiotherapy and Accuracy of Recommended Re-excisionsNCT06903468 · 2025-10-27

A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.NCT07095114 · 2025-08-18

Ultra Hypo-fractionated Adjuvant Whole Breast Radiation Therapy With Simultaneous Integrated Boost for Early-Stage Breast Cancer (H-ASSIST)NCT06902311 · 2025-02-19

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as TreatmentNCT06075953 · 2024-02-17

Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In SituNCT06218303 · 2024-02-07

Preoperative Partial Breast Irradiation in Early-Stage Breast CancerNCT06677944 · 2023-10-13

Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)NCT04985032 · 2022-08-15

Cryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In SituNCT05218044 · 2021-11-01

Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in SituNCT04666961 · 2021-02-03

Evaluation of Novel Iron-based Lymphatic Mapping Agent, Magtrace, for Delayed Sentinel Lymph Node Biopsy (SLNB) in Ductal Carcinoma In-Situ (DCIS)NCT06868238 · 2026-10-01

Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTionNCT06033092 · 2024-06-21

Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health SystemNCT06133647 · 2023-05-04

Excisional Vacuum-Assisted Breast BiopsyNCT05932758 · 2023-01-17

Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS)NCT03775213 · 2021-10-12

Subzero and Scorpion TrialNCT05032079 · 2020-11-16

Prospective Registry Trial for Single Port Robot-assisted Nipple Sparing Mastectomy (SPrNSM)NCT04866992 · 2020-02-01

The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery.NCT04248179 · 2019-11-29

BrUOG 351: PRE-OPERATIVE APBI USING NIBBNCT03437915 · 2019-03-01

Living Well After Breast SurgeryNCT03834532 · 2019-02-18

Patient Outcomes from Second Film-readers and Test Threshold Relaxation in Breast ScreeningNCT04365114 · 2018-10-01

The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation ExposureNCT03375892 · 2018-03-03

Intraoperative Radiation Therapy (IORT) in DCISNCT03216421 · 2017-09-12

ACTIVE_NOT_RECRUITING

Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCISNCT02926911 · 2017-02-22

ACTIVE_NOT_RECRUITING

The Mammography and Ultrasonography STudy for Breast Cancer Screening EffectivenessNCT02909426 · 2016-05-02

Preventing Persistent Pain and Reducing Depressive and Anxious Symptoms Following Mastectomy and LumpectomyNCT03430765 · 2015-06-21

Pilot Study of Oxytocin and microRNA Identification in NAF, Serum, and Tissue in Women With Breast CancerNCT02127073 · 2015-01-30

Naltrexone RCT for Treatment-Emergent Fatigue in Patients Receiving Radiation Therapy for Breast CancerNCT02137252 · 2014-05-01

A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in SituNCT01628536 · 2012-06-01

Safety and Efficacy Study of the Xoft® Axxent® eBx® IORT System®NCT01644669 · 2012-05-08

ACTIVE_NOT_RECRUITING

The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and LavageNCT02121873 · 2011-07-01

Breast Cancer Chemoprevention by SOM230, an IGF-I Action InhibitorNCT01372618 · 2011-06-01

Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal SymptomsNCT01194440 · 2011-02-01

Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast CancerNCT01138553 · 2010-06-01

A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in SituNCT01060345 · 2010-05-01

Effect of Pharmacogenomics Differences in Phase I and II Metabolism of Tamoxifen on Efficacy and ToxicityNCT00886535 · 2010-02-01

Selective Omission of Sentinel Lymph Node Biopsy in Mastectomy for Ductal Carcinoma in Situ: Identifying Eligible CandidatesNCT05961280 · 2010-01-01

Phase IV Trial to Evaluate Breast Brachytherapy Using the Mammosite-Ml®NCT01448447 · 2009-12-01

Lapatinib for Treatment of Ductal Carcinoma In Situ (DCIS) of the BreastNCT00857714 · 2009-04-01

Intraoperative Gamma Camera for Breast Cancer SurgeryNCT00757302 · 2008-09-01

Electronic Xoft Intersociety Brachytherapy Trial: Electronic Brachytherapy (EBT) For Treatment of Early Stage Breast CancerNCT00742222 · 2008-05-01

Breast MRI as a Preoperative Tool for DCISNCT00605982 · 2006-10-10

Common interventions

Leading sponsors

European Institute of Oncology2 University of Florida2 Xoft, Inc.2 Alliance Foundation Trials, LLC.1 Atossa Therapeutics, Inc.1 Barbara Ann Karmanos Cancer Institute1 Columbia University1 Dana-Farber Cancer Institute1 Duke University1 Finn, Olivera, PhD1 Gangnam Severance Hospital1 Glendale Adventist Medical Center d/b/a Adventist Health Glendale1 Indiana University1 Institut Cancerologie de l'Ouest1 Jaroslaw Hepel1

Trial status mix

COMPLETED18

RECRUITING10

TERMINATED6

ACTIVE_NOT_RECRUITING3

UNKNOWN2

WITHDRAWN2

SUSPENDED1

Phase mix

NA17

PHASE211

PHASE13

PHASE42

EARLY_PHASE11

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.